Both phthiocerol dimycocerosates and phenolic glycolipids are required for virulence of Mycobacterium marinum

Infection and Immunity

Volumn 80, Issue 4, 2012, Pages 1381-1389

  Yu, Jia ^a,b   Tran, Vanessa ^c   Li, Ming ^c   Huang, Xinghua ^a   Niu, Chen ^a   Wang, Decheng ^a   Zhu, Jianghua ^a   Wang, Jianping ^a   Gao, Qian ^a   Liu, Jun ^c  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYGROMYCIN; KANAMYCIN; MEMBRANE LIPID; PHENOLIC GLYCOLIPID; PHTHIOCEROL DIMYCOCEROSATE; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; GLYCOLIPID; LIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; GENE INSERTION; MYCOBACTERIOSIS; MYCOBACTERIUM MARINUM; NONHUMAN; PRIORITY JOURNAL; TRANSPOSON; ZEBRA FISH; ANIMAL; ATYPICAL MYCOBACTERIOSIS; BIOSYNTHESIS; CELL WALL; DRUG EFFECT; GENETICS; METABOLISM; MICROBIOLOGY; MUTATION; PATHOGENICITY; PATHOLOGY; PERMEABILITY; PHYSIOLOGY;

ANIMALS; BACTERIAL PROTEINS; CELL WALL; GLYCOLIPIDS; LIPIDS; MUTATION; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; MYCOBACTERIUM MARINUM; PERMEABILITY; ZEBRAFISH;

EID: 84860879169     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.06370-11     Document Type: Article

References (41)

1. Alexander DC, Jones JR, Tan T, Chen JM, Liu J. 2004. PimF, a mannosyltransferase of mycobacteria, is involved in the biosynthesis of phosphatidylinositol mannosides and lipoarabinomannan. J. Biol. Chem. 279: 18824-18833.
2. Alibaud L, et al. 2011. A Mycobacterium marinum TesA mutant defective for major cell wall-associated lipids is highly attenuated in Dictyostelium discoideum and zebrafish embryos. Mol. Microbiol. 80:919 -934.
3. Andreu N, Gibert I. 2008. Cell population heterogeneity in Mycobacterium tuberculosis H37Rv. Tuberculosis (Edinb.) 88:553-559.
4. Astarie-Dequeker C, et al. 2009. Phthiocerol dimycocerosates of M. tuberculosis participate in macrophage invasion by inducing changes in the organization of plasma membrane lipids. PLoS Pathog. 5:e1000289.
5. Azad AK, Sirakova TD, Fernandes ND, Kolattukudy PE. 1997. Gene knockout reveals a novel gene cluster for the synthesis of a class of cell wall lipids unique to pathogenic mycobacteria. J. Biol. Chem. 272:16741- 16745.
6. Azad AK, Sirakova TD, Rogers LM, Kolattukudy PE. 1996. Targeted replacement of the mycocerosic acid synthase gene in Mycobacterium bovis BCG produces a mutant that lacks mycosides. Proc. Natl. Acad. Sci. U. S. A. 93:4787- 4792.
7. Camacho LR, et al. 2001. Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall permeability barrier. J. Biol. Chem. 276:19845-19854.
8. Camacho LR, Ensergueix D, Perez E, Gicquel B, Guilhot C. 1999. Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis. Mol. Microbiol. 34:257-267.
9. Chavadi SS, et al. 2011. Inactivation of tesA reduces cell wall lipid production and increases drug susceptibility in mycobacteria. J. Biol. Chem. 286:24616 -24625.
10. Chen JM, et al. 2006. Roles of Lsr2 in colony morphology and biofilm formation of Mycobacterium smegmatis. J. Bacteriol. 188:633- 641.
11. Chen JM, Islam ST, Ren H, Liu J. 2007. Differential productions of lipid virulence factors among BCG vaccine strains and implications on BCG safety. Vaccine 25:8114-8122.
12. Cox JS, Chen B, McNeil M, Jacobs WR, Jr. 1999. Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Nature 402:79-83.
13. Domenech P, Reed MB. 2009. Rapid and spontaneous loss of phthiocerol dimycocerosate (PDIM) from Mycobacterium tuberculosis grown in vitro: implications for virulence studies. Microbiology 155:3532-3543.
14. Fernandes ND, Kolattukudy PE. 1998. A newly identified methylbranched chain fatty acid synthesizing enzyme from Mycobacterium tuberculosis var. bovis BCG. J. Biol. Chem. 273:2823-2828.
15. Ferreras JA, et al. 2008. Mycobacterial phenolic glycolipid virulence factor biosynthesis: mechanism and small-molecule inhibition of polyketide chain initiation. Chem. Biol. 15:51- 61.
16. Fitzmaurice AM, Kolattukudy PE. 1998. An acyl-CoA synthase (ACoAS) gene adjacent to the mycocerosic acid synthase (mas) locus is necessary for mycocerosyl lipid synthesis in Mycobacterium tuberculosis var. bovis BCG. J. Biol. Chem. 273:8033- 8039.
17. Gao LY, et al. 2003. Requirement for kasB in Mycobacterium mycolic acid biosynthesis, cell wall impermeability and intracellular survival: implications for therapy. Mol. Microbiol. 49:1547-1563.
18. Glickman MS, Cox JS, Jacobs WR, Jr. 2000. A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. Mol. Cell 5:717-727.
19. Hall-Stoodley L, Brun OS, Polshyna G, Barker LP. 2006. Mycobacterium marinum biofilm formation reveals cording morphology. FEMS Microbiol. Lett. 257:43- 49.
20. Hotter GS, et al. 2005. Transposon mutagenesis of Mb0100 at the ppe1-nrp locus in Mycobacterium bovis disrupts phthiocerol dimycocerosate (PDIM) and glycosylphenol-PDIM biosynthesis, producing an avirulent strain with vaccine properties at least equal to those of M. bovis BCG. J. Bacteriol. 187:2267-2277.
21. Humphreys IR, et al. 2006. A role for dendritic cells in the dissemination of mycobacterial infection. Microbes Infect. 8:1339 -1346.
22. Ioerger TR, et al. 2010. Variation among genome sequences of H37Rv strains of Mycobacterium tuberculosis from multiple laboratories. J. Bacteriol. 192:3645-3653.
23. Kana BD, et al. 2008. The resuscitation-promoting factors of Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitro. Mol. Microbiol. 67:672- 684.
24. Kirksey MA, et al. 2011. Spontaneous phthiocerol dimycocerosatedeficient variants of Mycobacterium tuberculosis are susceptible to gamma interferon-mediated immunity. Infect. Immun. 79:2829 -2838.
25. Middlebrook G, Dubos RJ, Pierce C. 1947. Virulence and morphological characteristics of mammalian tubercle bacilli. J. Exp. Med. 86:175-184.
26. Ng V, et al. 2000. Role of the cell wall phenolic glycolipid-1 in the peripheral nerve predilection of Mycobacterium leprae. Cell 103:511-524.
27. Onwueme KC, Ferreras JA, Buglino J, Lima CD, Quadri LE. 2004. Mycobacterial polyketide-associated proteins are acyltransferases: proof of principle with Mycobacterium tuberculosis PapA5. Proc. Natl. Acad. Sci. U. S. A. 101:4608-4613.
28. Onwueme KC, Vos CJ, Zurita J, Ferreras JA, Quadri LE. 2005. The dimycocerosate ester polyketide virulence factors of mycobacteria. Prog. Lipid Res. 44:259 -302.
29. Parish T, et al. 2003. Deletion of two-component regulatory systems increases the virulence of Mycobacterium tuberculosis. Infect. Immun. 71: 1134-1140.
30. Perez E, et al. 2004. Characterization of three glycosyltransferases involved in the biosynthesis of the phenolic glycolipid antigens from the Mycobacterium tuberculosis complex. J. Biol. Chem. 279:42574-42583.
31. Reed MB, et al. 2004. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431:84-87.
32. Ren H, et al. 2007. Identification of the lipooligosaccharide biosynthetic gene cluster from Mycobacterium marinum. Mol. Microbiol. 63:1345- 1359.
33. Rousseau C, et al. 2004. Production of phthiocerol dimycocerosates protects Mycobacterium tuberculosis from the cidal activity of reactive nitrogen intermediates produced by macrophages and modulates the early immune response to infection. Cell. Microbiol. 6:277-287.
34. Simeone R, et al. 2010. Delineation of the roles of FadD22, FadD26 and FadD29 in the biosynthesis of phthiocerol dimycocerosates and related compounds in Mycobacterium tuberculosis. FEBS J. 277:2715-2725.
35. Sinsimer D, et al. 2008. The phenolic glycolipid of Mycobacterium tuberculosis differentially modulates the early host cytokine response but does not in itself confer hypervirulence. Infect. Immun. 76:3027-3036.
36. Staropoli JF, Branda JA. 2008. Cord formation in a clinical isolate of Mycobacterium marinum. J. Clin. Microbiol. 46:2814 -2816.
37. Tobin DM, Ramakrishnan L. 2008. Comparative pathogenesis of Mycobacterium marinum and Mycobacterium tuberculosis. Cell. Microbiol. 10: 1027-1039.
38. Trivedi OA, et al. 2004. Enzymic activation and transfer of fatty acids as acyl-adenylates in mycobacteria. Nature 428:441- 445.
39. Trivedi OA, et al. 2005. Dissecting the mechanism and assembly of a complex virulence mycobacterial lipid. Mol. Cell 17:631- 643.
40. Tsenova L, et al. 2005. Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli. J. Infect. Dis. 192:98 -106.
41. Yu J, et al. 2011. MMAR_2770, a new enzyme involved in biotin biosynthesis, is essential for the growth of Mycobacterium marinum in macrophages and zebrafish. Microbes Infect. 13:33- 41.